Cite
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
MLA
Ying L. Liu, et al. “Delays from Neoadjuvant Chemotherapy to Interval Debulking Surgery and Survival in Ovarian Cancer.” International Journal of Gynecological Cancer, vol. 30, no. 10, Oct. 2020, pp. 1554–61. EBSCOhost, https://doi.org/10.1136/ijgc-2019-000989.
APA
Ying L. Liu, Qin C. Zhou, Iasonos, A., Filippova, O. T., Chi, D. S., Zivanovic, O., Sonoda, Y., Gardner, G., Broach, V., OCearbhaill, R., Konner, J. A., Aghajanian, C. A., Long, K., & Tew, W. (2020). Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer. International Journal of Gynecological Cancer, 30(10), 1554–1561. https://doi.org/10.1136/ijgc-2019-000989
Chicago
Ying L. Liu, Qin C. Zhou, Alexia Iasonos, Olga T. Filippova, Dennis S. Chi, Oliver Zivanovic, Yukio Sonoda, et al. 2020. “Delays from Neoadjuvant Chemotherapy to Interval Debulking Surgery and Survival in Ovarian Cancer.” International Journal of Gynecological Cancer 30 (10): 1554–61. doi:10.1136/ijgc-2019-000989.